Could Meta Be the Next $2 Trillion Titan?
With over 3.4 billion people engaging with at least one of Meta’s apps daily, the company already owns the world’s largest digital attention network. But now, it’s not just about scale, it’s about intelligence. Meta has embedded AI deep into its core product experiences, reshaping how users interact with content and how advertisers connect with audiences.
» Read more about: Could Meta Be the Next $2 Trillion Titan? »
Read More
2 Champion Traders Bought This Stock
To be the best sometimes you simply have to follow the best and see what they are doing. That old adage applies to trading Nvidia recently when, on the same day, both Oliver Kell, who posted a 941.1% gain to win the US trading championship a few years ago, and Mark Minervini bought it.
Mark has famously become one of the most successful traders of all time,
» Read more about: 2 Champion Traders Bought This Stock »
Read More
1 No-Brainer Cable Stock to Buy
Usually cable stocks should be avoided like the plague. The trend towards cord-cutting has been unrelenting as streaming services like Netflix came to the forefront over the past decade. After all, why pay $80 per month when you can pay $10 for a range of movies on your favorite streaming platform?
But most of the well-known cable companies compete against each other in city environments and have to fend off stark competition.
» Read more about: 1 No-Brainer Cable Stock to Buy »
Read More
1 Virtually Unknown Driller Is Way Undervalued
When it comes to energy stocks, some names leap off the pages. Exxon, Valero, Conoco Phillips are all well-known but what about the lesser known names, is there an opportunity to find one trading at bargain basement prices there?
We stumbled across one such firm that likely has never crossed the radars of most investors.
» Read more about: 1 Virtually Unknown Driller Is Way Undervalued »
Read More
Why Bill Ackman Just Bet $2 Billion on Uber
In February, Pershing Square manager Bill Ackman revealed that his fund had deployed around $2 billion worth of its capital early in the year to buy a little over 30 million shares of Uber (NYSE:UBER).
Sometimes referred to as a new Warren Buffett for his value-driven investment strategies that in many ways mirror the Oracle of Omaha’s,
» Read more about: Why Bill Ackman Just Bet $2 Billion on Uber »
Read MoreThe Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Spotlight
Spotlight: What to Buy If Things Get Crazy Soon
Among the first lessons any great investor learns is “Don’t Fight The Fed.” Simply put, it means when the Fed is accommodative and engaging in quantitative easing, money is cheap and economies boom. Some call this the Fed Put because as markets fall, the Federal Reserve acts swiftly to provide liquid support by buying bonds.
» Read more about: Spotlight: What to Buy If Things Get Crazy Soon »
Read MoreThe Daily
Battle of the Tech Giants: Is MGK or VUG the Better ETF for Long-Term Growth?
Explore how differences in sector focus, diversification, and cost structure set these two growth ETFs apart for investors.
The Vanguard Growth ETF (VUG +0.00%) and the Vanguard Mega Cap Growth ETF (MGK +0.01%) both offer broad U.S.
» Read more about: Battle of the Tech Giants: Is MGK or VUG the Better ETF for Long-Term Growth? »